by Jeanine Verbeek | Feb 17, 2026
Startups Back to overview Immunara is developing a novel immune-priming technology based on single domain antibodies to direct patients’ own immune systems against cancer. Immunara is developing a novel precision immunotherapy designed to prime the immune...
by Jeanine Verbeek | Feb 17, 2026
Startups Back to overview Levels Dx detects liver cancer early—when it’s still curable Levels Diagnostics (Levels Dx) is a Dutch biotech company developing a next-generation blood test for the early detection of hepatocellular carcinoma (HCC), the most common and...
by Jeanine Verbeek | Feb 17, 2026
Startups Back to overview Tolvac Therapeutics develops tolerogenic therapies to cure autoimmune diseases using proprietary platform technology Millions of people worldwide suffer from rheumatoid arthritis (RA), especially in developed countries where this condition...
by Jeanine Verbeek | Feb 10, 2026
Startups Back to overview VitroScan offers stateoftheart predictive assays that enable clinicians and patients to individualize treatment strategies, thereby improving efficacy, reducing adverse events, and enhancing patient outcomes In modern oncology, the ability...
by Jeanine Verbeek | Feb 6, 2026
Startups Back to overview Omivera is a CRO that uses their proprietary CellEKT profiling technology to assess the safety and efficacy of the next generation of kinase targeting therapies. Omivera is a chemical proteomics company based in Leiden, dedicated to helping...
